The role of salivary cortisol measured by liquid chromatographytandem mass spectrometry in the diagnosis of subclinical hypercortisolism

European Journal of Endocrinology

Volumn 168, Issue 3, 2013, Pages 289-296

  Palmieri, S ^a   Morelli, V ^a   Polledri, E ^a   Fustinoni, S ^a   Mercadante, R ^a   Olgiati, L ^a   Eller Vainicher, C ^a   Cairoli, E ^a   Zhukouskaya, V V ^a   Beck Peccoz, P ^a   Chiodini, I ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPERTENSION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA ANALYSIS; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADRENAL CORTEX; ADRENAL GLAND NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SALIVA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84874069523     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0803     Document Type: Article

References (38)

1. Terzolo M, Bovio S, Reimondo G., Pia A, Osella G, Borretta G & Angeli A. Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinology and Metabolism Clinics of North America 2005 34 423-439. (doi:10.1016/j.ecl.2005.01. 008)
2. Nieman LK, Biller BM, Findling J.W., Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
3. Chiodini I. Diagnosis and treatment of subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2011 96 1223-1236. (doi:10.1210/jc.2010-2722)
4. Grumbach MM, Biller BM, Braunstein G.D., Campbell KK, Carney JA, Godley PA, Harris E.L., Lee JK, Oertel YC, Posner MC et al. Management of the clinically inapparent adrenal masses ("incidentaloma"). Annals of Internal Medicine 2003 138 424-429.
5. Garrapa GG, Pantanetti P, Arnaldi G., Mantero F & Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5301-5306. (doi:10.1210/jc.86.11.5301)
6. Tauchmanova L, Rossi R, Biondi B., Pulcrano M, Nuzzo V, Palmieri E.A., Fazio S & Lombardi G. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2002 87 4872-4878. (doi:10.1210/jc.2001-011766)
7. Rossi R, Tauchmanova L, Luciano A., Di Martino M, Battista C, Del Viscovo L, Nuzzo V & Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448. (doi:10.1210/jc.85.4.1440)
8. Chiodini I, Morelli V, Masserini B., Salcuni AS, Eller-Vainicher C, Viti R, Coletti F., Guglielmi G, Battista C, Carnevale V et al. Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. Journal of Clinical Endocrinology and Metabolism 2009 94 3207-3214. (doi:10.1210/jc.2009-0468)
9. Eller-Vainicher C., Morelli V, Ulivieri F.M., Palmieri S., Zhukouskaya VV, Cairoli E, Pino R, Naccarato R., Scillitani A, Beck-Peccoz P et al. Bone quality as measured by trabecular bone score (TBS) in patients with adrenal incidentalomas with and without subclinical hypercortisolism. Journal of Bone and Mineral Research 2012 27 2223-2230. (doi:10.1002/jbmr.1648)
10. Toniato A, Merante-Boschin I, Opocher G., Pelizzo MR, Schiavi F & Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Annals of Surgery 2009 249 388-391. (doi:10.1097/SLA.0b013e31819a47d2)
11. Chiodini I, Morelli V, Salcuni A.S., Eller-Vainicher C, Torlontano M, Coletti F., Iorio L, Cuttitta A, Ambrosio A., Vicentini L et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2010 95 2736-2745. (doi:10.1210/jc.2009-2387)
12. Tsagarakis S, Vassiliadi D & Thalassinos N. Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. Journal of Endocrinological Investigation 2006 29 471-482.
13. Stewart PM. Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. Journal of Clinical Endocrinology and Metabolism 2010 95 2618-2620. (doi:10.1210/jc.2010-0633)
14. Tabarin A & Perez P. Pros and cons of screening for occult Cushing syndrome. Nature Reviews. Endocrinology 2011 7 445-455. (doi:10.1038/nrendo. 2011.51)
15. Valli N, Catargi B, Ronci N., Vergnot V, Leccia F, Ferriere J.M., Chene G., Grenier N, Laurent F & Tabarin A. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. European Journal of Endocrinology 2001 144 401-408. (doi:10.1530/eje.0.1440401)
16. Eller-Vainicher C., Morelli V, Salcuni A.S., Battista C., Torlontano M, Coletti F, Iorio L., Cairoli E, Beck-Peccoz P, Arosio M et al. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. European Journal of Endocrinology 2010 163 925-935. (doi:10.1530/EJE-10-0602)
17. Newell-Price J., Trainer P, Besser M & Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews 1998 19 647-672. (doi:10.1210/er.19.5.647)
18. Mazzuco TL, Bourdeau I & Lacroix A. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment. Current Opinion in Endocrinology, Diabetes, and Obesity 2009 16 203-210. (doi:10.1097/MED. 0b013e32832b7043)
19. Nunes ML, Vattaut S, Corcuff J.B., Rault A., Loiseau H, Gatta B, Valli N., Letenneur L & Tabarin A. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. Journal of Clinical Endocrinology and Metabolism 2009 94 456-462. (doi:10.1210/jc.2008-1542)
20. Masserini B, Morelli V, Bergamaschi S., Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini M.A., Scillitani A., Ambrosi B, Beck-Peccoz P et al. The limited role of midnight salivary cortisol in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas. European Journal of Endocrinology 2009 160 87-92. (doi:10.1530/EJE-08-0485)
21. Kidambi S, Raff H & Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. European Journal of Endocrinology 2007 157 725-731. (doi:10.1530/EJE-07-0424)
22. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 3647-3655. (doi:10.1210/jc.2009-1166)
23. Sereg M, Toke J, Patócs A, Varga I., Igaz P, Szücs N, Horányi J, Pusztai P., Czirják S, Gláz E et al. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Steroids 2011 76 38-42. (doi:10.1016/j.steroids.2010.08.007)
24. Baid SK, Sinai N, Wade M., Rubino D & Nieman LK. Radioimmunoassay and tandem mass spectrometry measurement of bed-time salivary cortisol levels: a comparison of assays to establish hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2007 92 3102-3107. (doi:10.1210/jc.2006-2861)
25. Owen LJ, Haslma S, Adaway J.E., Wood P., Glenn C & Keevil BG. A simplified liquid chromatography tandem mass spectrometry assay, using on-line solid-phase extraction, for the quantitation of cortisol in saliva and comparison with a routine DELFIA method. Annals of Clinical Biochemistry 2010 47 131-136. (doi:10.1258/acb.2009.009053)
26. Mei-Wah Fong B, Tam S & Sze-Yin Leung K. Improved liquid chromatography-tandem mass spectrometry method in clinical utility for the diagnosis of Cushing's syndrome. Analytical and Bioanalytical Chemistry 2010 396 783-790. (doi:10.1007/s00216-009-3247-1)
27. Zerikly RK, Amiri L, Faiman C., Gupta M, Singh RJ, Nutter B, Kennedy L., Hatipoglu B, Weil RJ & Hamrahian AH. Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism 2010 95 4555-4559. (doi:10.1210/jc.2009-2458)
28. Mancia G, De Backer G, Dominiczak A, Cifkova R., Fagard R, Germano G, Grassi G., Heagerty AM, Kjeldsen SE, Laurent S et al. ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. Journal of Hypertension 2007 25 1105-1187. (doi:10.1097/HJH.0b013e3281fc975a)
29. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 S5-S20. (doi:10.2337/diacare.26.2007. S5)
30. Kanis JA, Melton LJ III, Christiansen C, Johnston CC & Khaltaev NSO. The diagnosis of osteoporosis. Journal of Bone and Mineral Research 1994 9 1137-1141. (doi:10.1002/jbmr. 5650090802)
31. 2002 NIH State-of-the-Science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consensus and State-of-the-Science Statements 19 1-25 (Review).
32. Simonelli C, Adler RA, Blake G.M., Caudill JAP, Khan A, Leib E., Maricic M, Prior JC, Eis S.R., Rosen C et al. Dual-Energy X-Ray Absorptiometry Technical issues: The 2007 ISCD Official Positions. Journal of Clinical Densitometry 2008 1 109-122. (doi:10.1016/j.jocd.2007.12.009)
33. Genant HK, Wu CY, van Knijk C & Nevitt M. Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research 1993 8 1137-1148. (doi:10.1002/jbmr. 5650080915)
34. Findling JW & Raff H. Cushing's syndrome: important issues in diagnosis and management. Journal of Clinical Endocrinology and Metabolism 2006 91 3746-3753. (doi:10.1210/jc.2006-0997)
35. Tateishi Y, Kouyama R, Mihara M., Doi M, Yoshimoto T & Hirata Y. Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome. Endocrine Journal 2012 59 283-289. (doi:10.1507/endocrj. EJ11-0204)
36. Erickson D, Singh RJ, Sathananthan A, Vella A & Bryant SC. Latenight salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay. Clinical Endocrinology 2012 4 467-472. (doi:10.1111/j.1365-2265. 2011.04239.x)
37. Raff H. Cushing's syndrome: diagnosis and surveillance using salivary cortisol. Pituitary 2012 15 64-70. (doi:10.1007/s11102-011-0333-0)
38. Gröschl M & Rauh M. Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids 2006 71 1097-1100. (doi:10.1016/j.steroids.2006.09.007)